164 related articles for article (PubMed ID: 12597230)
1. Extended thromboprophylaxis after hip or knee replacement.
Friedman RJ
Orthopedics; 2003 Feb; 26(2 Suppl):s225-30. PubMed ID: 12597230
[TBL] [Abstract][Full Text] [Related]
2. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
Whang PG; Lieberman JR
Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
[TBL] [Abstract][Full Text] [Related]
3. Nonadherence in outpatient thrombosis prophylaxis with low molecular weight heparins after major orthopaedic surgery.
Wilke T; Moock J; Müller S; Pfannkuche M; Kurth A
Clin Orthop Relat Res; 2010 Sep; 468(9):2437-53. PubMed ID: 20333493
[TBL] [Abstract][Full Text] [Related]
4. Dabigatran vs. low molecular weight heparin in preventing venous thromboembolism after elective hip and knee arthroplasty: evaluation of selected clinical parameters.
Mrozik D; Jackiewicz A; Krzemiński M
Pol Orthop Traumatol; 2012 Oct; 77():111-4. PubMed ID: 23306297
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registry.
Beyer-Westendorf J; Lützner J; Donath L; Tittl L; Knoth H; Radke OC; Kuhlisch E; Stange T; Hartmann A; Günther KP; Weiss N; Werth S
Thromb Haemost; 2013 Jan; 109(1):154-63. PubMed ID: 23197272
[TBL] [Abstract][Full Text] [Related]
6. Optimal duration of prophylaxis for venous thromboembolism following total hip arthroplasty and total knee arthroplasty.
Friedman RJ
J Am Acad Orthop Surg; 2007 Mar; 15(3):148-55. PubMed ID: 17341671
[TBL] [Abstract][Full Text] [Related]
7. Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement. A randomized, double-blind, placebo-controlled trial.
Heit JA; Elliott CG; Trowbridge AA; Morrey BF; Gent M; Hirsh J
Ann Intern Med; 2000 Jun; 132(11):853-61. PubMed ID: 10836911
[TBL] [Abstract][Full Text] [Related]
8. Low-molecular-weight heparin: the optimal duration of prophylaxis against postoperative venous thromboembolism after total hip or knee replacement.
Heit JA
Thromb Res; 2001 Jan; 101(1):V163-73. PubMed ID: 11342096
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty.
Mantilla CB; Horlocker TT; Schroeder DR; Berry DJ; Brown DL
Anesthesiology; 2003 Sep; 99(3):552-60; discussion 5A. PubMed ID: 12960538
[TBL] [Abstract][Full Text] [Related]
10. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
Dorr LD; Gendelman V; Maheshwari AV; Boutary M; Wan Z; Long WT
J Bone Joint Surg Am; 2007 Dec; 89(12):2648-57. PubMed ID: 18056497
[TBL] [Abstract][Full Text] [Related]
11. Low risk of thromboembolic complications after fast-track hip and knee arthroplasty.
Husted H; Otte KS; Kristensen BB; Ørsnes T; Wong C; Kehlet H
Acta Orthop; 2010 Oct; 81(5):599-605. PubMed ID: 20919815
[TBL] [Abstract][Full Text] [Related]
12. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
Lu X; Lin J
BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
[TBL] [Abstract][Full Text] [Related]
13. Wound complications following rivaroxaban administration: a multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty.
Jameson SS; Rymaszewska M; Hui AC; James P; Serrano-Pedraza I; Muller SD
J Bone Joint Surg Am; 2012 Sep; 94(17):1554-8. PubMed ID: 22832942
[TBL] [Abstract][Full Text] [Related]
14. Extended thromboprophylaxis following lower limb arthroplasty: what do the clinical trials mean?
Cohen AT; Khushal A
Haemostasis; 2000; 30 Suppl 2():88-94; discussion 82-3. PubMed ID: 11251349
[TBL] [Abstract][Full Text] [Related]
15. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
[TBL] [Abstract][Full Text] [Related]
16. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.
Camporese G; Bernardi E; Prandoni P; Noventa F; Verlato F; Simioni P; Ntita K; Salmistraro G; Frangos C; Rossi F; Cordova R; Franz F; Zucchetta P; Kontothanassis D; Andreozzi GM;
Ann Intern Med; 2008 Jul; 149(2):73-82. PubMed ID: 18626046
[TBL] [Abstract][Full Text] [Related]
17. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH
J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307
[TBL] [Abstract][Full Text] [Related]
18. Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
Matharu GS; Kunutsor SK; Judge A; Blom AW; Whitehouse MR
JAMA Intern Med; 2020 Mar; 180(3):376-384. PubMed ID: 32011647
[TBL] [Abstract][Full Text] [Related]
19. The risk of venous thromboembolism in non-large-joint surgeries.
Muntz JE
Orthopedics; 2003 Feb; 26(2 Suppl):s237-42. PubMed ID: 12597232
[TBL] [Abstract][Full Text] [Related]
20. Reduction of out-of-hospital symptomatic venous thromboembolism by extended thromboprophylaxis with low-molecular-weight heparin following elective hip arthroplasty: a systematic review.
O'Donnell M; Linkins LA; Kearon C; Julian J; Hirsh J
Arch Intern Med; 2003 Jun; 163(11):1362-6. PubMed ID: 12796074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
